Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
24.92
+0.64 (2.64%)
At close: Dec 20, 2024, 4:00 PM
25.01
+0.09 (0.36%)
After-hours: Dec 20, 2024, 5:31 PM EST
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $14.68 billion as of December 20, 2024. Its market cap has increased by 14.71% in one year.
Market Cap
14.68B
Enterprise Value
21.29B
1-Year Change
14.71%
Ranking
Category
Stock Price
$24.92
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has decreased from $15.76B to $14.68B, a decrease of -6.84%. That is a compound annual growth rate of -1.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 11.07B | -11.40% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| United Therapeutics | 16.03B |
| Align Technology | 15.81B |
| Moderna | 15.06B |
| Baxter International | 14.91B |
| Viatris | 14.52B |
| Avantor | 14.27B |
| Fresenius Medical Care AG | 13.85B |
| Neurocrine Biosciences | 13.68B |